Antisera, Latex Agglutination, Cryptococcus Neoformans
Catalogue number R2456096, listed by Oxoid, Ltd., United Kingdom, under Antisera, Latex Agglutination, Cryptococcus Neoformans. 1 manufacturer in China is registered for this product code.
1manufacturer
1catalogue number
Who Else Makes It
Registered in Tianjin.
| Manufacturer | City | Province | Registered as | Device types |
|---|---|---|---|---|
| Genobio Pharmaceutical Co., Ltd. | Tianjin | Tianjin | Manufacturer | 1 |
Record
| Listed by | Oxoid, Ltd., United Kingdom |
|---|---|
| FDA product code | GMD |
| Device type | Antisera, Latex Agglutination, Cryptococcus Neoformans |
| Device class | Class 2 |
| Regulation | 21 CFR 866.3165 |
| Establishment | Specification developer, Manufacturer, Exporter |
| Record published | 2016-09-24 |
| Record revised | 2018-03-29 (version 2) |
Specifications
| MRI safety | Labeling does not contain MRI Safety Information |
|---|---|
| Label carries | lot or batch number, expiry date |
Catalogue Numbers
| Catalogue number | Size | Status |
|---|---|---|
| R2456096 | In distribution |
Same Product Code
| Product | Sold by | Catalogue numbers |
|---|---|---|
| Immy | Immuno-Mycologics, Inc. | 6 |
| Antisera, Latex Agglutination, Cryptococcus Neoformans | Remel, Inc. | 2 |
| Cryptococcal Antigen Latex Agglutination System (Calas) | Meridian Bioscience, Inc. | 1 |
| Calas Pronase | Meridian Bioscience, Inc. | 1 |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.